Technical project studies; research and development [for others]; chemical analysis; chemical research; bacteriological research; biological research; packaging design; hosting computer sites [web sites]; computer software design; physics research.

Medicines for human purposes; dietetic foods adapted for medical purposes; air freshening preparations (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); biological preparations for veterinary purposes; pesticides; pharmaceutical preparations; chemical preparations for medical purposes; injection (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); tablet (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); raw material medicine (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations).

Meat; poultry and game; meat extracts; tinned meat; preserved, dried and cooked fruits and vegetables; jellies; jams; eggs; milk; milk products; dairy products; cheese; butter; yoghurt; milk beverages; edible oils and fats; pickles.

Cake pastry; food pastes; sweets; coffee: tea; cocoa; sugar; rice; tapioca; artificial coffee; flour; preparations made from cereals; bread; biscuits; tarts; pastries; pralines; edible ices; honey; syrup; pepper; vinegar; sauces; dressings; spices; ice; coffee, cocoa and chocolate-based beverages.

Meat, fish, poultry, game and products made therefrom; meat extracts; edible oils and fats; all included in Class 29.

Database management; database marketing; computerised database management; advertising for databases; database administration; compilation and systematisation of information and data in databases; collection, updating and maintenance of data in databases; provision of information relating to the updating and maintenance of data in databases.

Education; providing of training; entertainment services; sporting activities; cultural activities; providing of training and instruction; providing of electronic newspapers and magazines on the Internet and on intranets; operation of further education, training and qualification facilities; coaching; demonstration lessons in practical exercises; services provided by a university, namely education and teaching, distance learning, distance studies, distance courses, conducting academic examinations, research and teaching, further education consultancy, training consultancy, operation of sports facilities, conducting courses of study, conducting academic examinations; knowledge transfer (training) using internet-based media; organisation and conducting of workshops [training]; presentation of training content for teaching purposes; training and further education and parenting consultancy; information on events; creating publications using a computer; personnel development through basic and further training; services of a sound and television studio; internet services, namely providing entertainment programmes on the internet; management and business training; editing [processing] of video tapes; multimedia services, namely production of multimedia presentations; organisation and staging of events, namely cultural and/or sporting events and for teaching purposes; organisation of and conducting seminars, conferences, congresses , symposiums, exhibitions, conferences, concerts, workshops, colloquiums, further training, training, seminars and teaching, further training and teaching events; publication of books, printed works, publishing and printed products, texts, magazines in electronic form, also on the internet and intranet; publication of books, printed works, publishing and printed products, texts, magazines; organisation of competitions.

Clothing *.

Advertising.

Toiletry preparations; animal and pet care products, namely, animal humectant, namely, moisturizers and conditioners, animal shampoo; oat based cosmetic products for animals, namely, animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms; avenanthramides and oat beta glucan for use as ingredients in cosmetics.

Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications.

Toiletry preparations; Animal and pet care products, namely, animal humectant, namely, moisturizers and conditioners, animal shampoo; oat based cosmetic products for animals, namely, animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms; avenanthramides and oat beta glucan for use as ingredients in cosmetics.

Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications.